Previous Article in event
Microwave Preparation of Uniform CeO2/Organo-Clay Nanoparticles and its Composition with Resin EpoxyPrevious Article in session
Next Article in event
A Simplified Microwave-Assisted Synthesis of NiMoO4 Nanoparticles by Using Organic Driving Agent and Study of Photocatalytic ActivityNext Article in session
Validated Liquid Chromatography/Tandem Mass Spectrometry Method for Determination and Pharmacokinetic Study of Metolazone in Rat Plasma
Published: 31 October 2014 by MDPI in The 18th International Electronic Conference on Synthetic Organic Chemistry session Bioorganic, Medicinal and Natural Products Chemistry
Abstract: A simple, highly sensitive and rapid LC-MS/MS method has been developed and validated for the quantification of metolazone in rat plasma using irbesartan as internal standard (IS). After simple protein precipitation extraction by acetonitrile, the analyte and IS were extracted from 50 μL plasma sample on an Agilent Poroshell 120, EC- C18 (50 mm × 4.6 mm, i.d., 2.7 μm) column using 5μL injection volume with a total run time of 2 min. Acidified methanol/water mixture was used as a mobile phase. The parent/product ion transitions for metolazone (m/z 366.1/258.9) and IS (m/z 429.2/207.0) were monitored on a triple quadrupole mass spectrometer, operating in the multiple reaction monitoring and positive ion mode. The method was found to be linear in the range of 0.05 – 200 metolazone. The method was validated with respect to selectivity, linearity, accuracy, precision, recovery and stability according to accepted regulatory guidelines. The described method was successfully applied to preclinical pharmacokinetic studies of analytes after an oral administration of metolazone (0.5 mg/kg) in rats.
Keywords: LC-MS/MS; pharmacokinetic; metolazone; validated; rat; plasma